Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G Viridian Therapeutics, Filed by: Point72 Asset Management, L.P.

August 20, 2026 4:15 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/20/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/20/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/20/2026

Comments accompanying signature: Exhibit 99.1: Joint Filing Agreement
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

ATTACHMENTS / EXHIBITS

JOINT FILING AGREEMENT

Categories

SEC Filings